ALT5 Sigma (NASDAQ:ALTS) saw its share price dip on Friday as the fintech company explores collaborations across AI data centers and payment systems.

This movement follows the announcement of a non-binding memorandum of understanding with Nano Labs Ltd (NASDAQ:NA), indicating a potential partnership in AI-native technologies.

The memorandum outlines a structured evaluation process for collaboration in three key areas: AI data centers, Agent Cloud, and AI-native payments.

The companies plan to conduct a 90-day evaluation period to assess how their respective capabilities can be integrated to support emerging AI-driven systems.

The broader market saw gains on Thursday, with the technology sector rising 1.95%. ALT5’s increase occurred while major indices like the Nasdaq rose 1.33%, suggesting the stock is moving in line with broader market trends.

Technical Analysis

ALT5 Sigma is currently trading 14% below its 20-day simple moving average (SMA), indicating short-term weakness, and 29.4% below its 50-day SMA, which suggests ongoing bearish momentum. The stock is also trading 39.5% below its 100-day SMA, reflecting a longer-term downtrend.

The relative strength index (RSI) is at 32.82, which is neutral but suggests the stock may be approaching oversold territory. This level indicates a potential reversal if buying interest increases.

  • Key Resistance: $1.00 — A psychological level that could attract selling pressure.
  • Key Support: 85 cents — A level where buyers may step in to prevent further declines.

The stock has seen a significant decline of 85.22% over the past 12 months, which reflects a challenging year for ALT5 Sigma. Currently, it is near the lower end of its 52-week range, suggesting that it has struggled to maintain higher price levels.

This collaboration with Nano Labs could enhance ALT5’s capabilities in the rapidly evolving AI space, potentially positioning the company for future growth amid increasing demand for AI technologies in financial services.

Earnings & Analyst Outlook

ALT5 Sigma is slated to provide its next financial update on May 12, 2026 (estimated).

  • EPS Estimate: Loss of 18 cents (down from N/A YoY)
  • Revenue Estimate: $5.51 Million (down from N/A YoY)

Analyst Consensus & Recent Actions: The stock carries a N/A Rating. No recent analyst actions available.

Price Action

Price Activity: ALT5 Sigma shares were down 1% at $0.84 on Friday, according to Benzinga Pro data. Nano Labs shares are trading higher by 0.41% to $2.42.

Image: Shutterstock